SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated April 22, 2025, reports a transaction in the company's own shares. The filing details a share repurchase executed on April 17, 2025, pursuant to a non-discretionary agreement with Citigroup Global Markets Limited entered into on February 24, 2025.
Key Financial Metrics and Transaction Details
- Shares Purchased: 684,200 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,314.50p; highest price paid was 1,337.50p.
- Average Price: Volume-weighted average price paid was 1,324.48p.
- Trading Venue: All transactions occurred on the London Stock Exchange (XLON).
- Treasury Shares: Following this purchase, GSK holds 199,655,825 ordinary shares in treasury.
- Shares in Issue: 4,115,579,330 ordinary shares (excluding treasury shares).
- Voting Rights: Total voting rights are 4,115,579,330.
Material Changes and Program Progress
This transaction is part of GSK's existing buyback programme. Since the programme's commencement on February 24, 2025, the company has purchased an aggregate of 30,585,522 ordinary shares. The purchased shares are held as Treasury shares and do not carry voting rights.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, outlook, or management commentary regarding operational performance. It includes a standard cautionary statement noting that forward-looking statements are subject to risks and uncertainties, referencing the Risk Factors section (pages 277 to 285) of the GSK 2024 Annual Report on Form 20-F.
Investor Verification Checklist
- Verify the total number of treasury shares held (199,655,825) against the company's latest capital structure disclosures.
- Confirm the remaining authorization under the buyback programme initiated on February 24, 2025.
- Review the Risk Factors in the 2024 Annual Report on Form 20-F for context on forward-looking statements.
- Note that the filing does not provide data on revenue, profit, cash flow, or debt levels; these metrics are not applicable to this specific transaction report.